Context This overview presents the updated European Association of Urology (EAU)
guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). Objective To …

Context Treatment of metastatic urothelial carcinoma is currently undergoing a rapid
evolution. Objective This overview presents the updated European Association of Urology …

Background Little is known about health-related quality of life (HRQOL) following treatment
for bladder cancer (BC). Objective To determine this, we undertook a cross-sectional survey …

Background There has been increasing interest in en bloc resection of bladder tumour
(ERBT) as an oncologically noninferior alternative to transurethral resection of bladder …

This Seminar presents the current best practice for the diagnosis and management of
bladder cancer. The scope of this Seminar ranges from current challenges in pathology …

Background BC2001, the largest randomised trial of bladder-sparing treatment for muscle-
invasive bladder cancer (MIBC), demonstrated improvement in locoregional control by …

Artesunate is a kind of derivative of artemisinin, which possesses potent anti-cancer effect in
addition to its anti-malarial property. And autophagy was a highly conserved process …

The fact that there are now five immune checkpoint inhibitor (ICI) monoclonal antibodies
approved since 2016 that target programmed cell death protein 1 or programmed death …

Objectives (1) To investigate whether a contrast-free biparametric MRI (bp-MRI) including T2-
weighted images (T2W) and diffusion-weighted images (DWI) can be considered an …

Simple Summary Bladder cancer is a complex disease, the sixth most common cancer, and
one of the most expensive cancers to treat. In the last few decades, there has been a …